StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — Somil Mehta, Sharekhan

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

bySomil Mehta, SharekhanHorizon: NA (inferred 1–3 months)28 Aug 2026via CNBC Awaaz.

Entry₹5,048Inferred
Target₹5,400
Total upside +6.97% (call closed)
Stop loss₹4,850-3.92% risk
Exit₹4,8504 Sept 2026, 12:09 pm
Stop-loss hit-3.92%
Follow Somil Mehta for new calls(34% target hit, 77 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 1 active Short-term call on TORNTPHARMSee 45 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Sept 2026
9 supporting3 neutral0 opposing
Supports the BUY call (9)

Torrent Pharma Plans Drug Discovery Return After Decade of M&A

NewsGoogle News·22 Aug · 2w ago

(opens in new tab)

Torrent Pharma Share Price: 10 साल बाद कंपनी का बड़ा फैसला! दवा रिसर्च में वापसी, क्या निवेशकों को होगा फायदा?

NewsGoogle News·22 Aug · 2w ago

(opens in new tab)

Ruby Mills sells The Ruby 33rd floor to Torrent Pharma for ₹124.08 crore

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)

Ruby Mills शेयर में ₹124 करोड़ का बड़ा निवेश! कंपनी ने बिल्डिंग का हिस्सा बेचा

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)

4 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·19 Aug · 2w ago

Neutral / worth noting (3)

Torrent Pharma Share: Q1 முடிவுகள்! வருவாய் ஜோர், லாபம் மிதமோ?

NewsGoogle News·17 Aug · 2w ago

(opens in new tab)

Torrent Pharma assigned ESG rating of 70 by NSE Sustainability

NewsGoogle News·11 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from Somil Mehta, Sharekhan

Every call and its outcome